Related Experiment Videos
Decreased expression of glutathione peroxidase mRNA in thyroid anaplastic carcinoma
Yukiko Hasegawa1, Toru Takano, Akira Miyauchi
1Department of Laboratory Medicine, Osaka University Medical School, D2, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
Abstract:
Our recent study using serial analysis of gene expression show the decreased expression of glutathione peroxidase (GPx), an antioxidant enzyme, in an anaplastic carcinoma. To clarify the expression of GPx in various kinds of thyroid tumors, the expression levels of GPx mRNA in 79 benign and malignant thyroid tissues were measured by means of real-time quantitative reverse transcription-polymerase chain reaction. A decreased expression of GPx mRNA was observed in all of five anaplastic carcinomas and some of the papillary carcinomas. A molecular-based therapy which produces O(2) radical may be considered as an alternative choice for the treatment of anaplastic carcinomas.
Insights
Glutathione peroxidase (GPx) expression is decreased in anaplastic and some papillary thyroid carcinomas. This finding suggests novel therapeutic strategies for anaplastic thyroid cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Thyroid cancer encompasses a range of tumors with varying prognoses.
- Glutathione peroxidase (GPx) is a key antioxidant enzyme.
- Previous studies indicated reduced GPx expression in anaplastic carcinoma.
Purpose of the Study:
- To investigate GPx mRNA expression across diverse thyroid tumor types.
- To determine if GPx levels correlate with specific thyroid cancer classifications.
Main Methods:
- Real-time quantitative reverse transcription-polymerase chain reaction (RT-qPCR) was employed.
- GPx mRNA levels were measured in 79 benign and malignant thyroid tissue samples.
Main Results:
- Significantly decreased GPx mRNA expression was detected in all five anaplastic carcinomas analyzed.
- Reduced GPx mRNA levels were also observed in a subset of papillary thyroid carcinomas.
- GPx expression patterns varied between benign and malignant thyroid tissues.
Conclusions:
- GPx downregulation is a characteristic feature of anaplastic thyroid carcinoma.
- Altered GPx expression may serve as a biomarker for thyroid malignancy.
- Therapeutic approaches involving oxygen (O2) radical generation could be explored for anaplastic thyroid cancer treatment.